Literature DB >> 9658388

Overproduction of soluble, extracellular cytotoxin alpha-sarcin in Escherichia coli.

D Parente1, G Raucci, L D'Alatri, G d'Estais, S Novelli, A Pacilli, M P Saccinto, A Mele, R De Santis.   

Abstract

The goal of the present study was to establish the condition to obtain preparative amounts of the recombinant cytotoxin alpha-sarcin to be used for immunoconjugate production. alpha-Sarcin cDNA was isolated from Aspergillus giganteus strain MDH 18,894 and its expression in Escherichia coli was attempted by the use of both two-cistron and fusion protein-expression systems. Whereas the former resulted in low intracellular expression level of recombinant alpha-sarcin (r-Sar), the latter allowed high-level expression of the fusion protein in the culture supernatant. A variant form of alpha-sarcin with an additional threonine residue in position 1 (Thr-Sar) was obtained by proteolytic processing of the fusion protein with a final yield after purification of 40 mg/L of culture. Both recombinant proteins r-Sar and Thr-Sar were identical to native a-sarcin with respect to the biochemical properties and to the in vitro biological activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658388     DOI: 10.1007/BF02760812

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  20 in total

1.  Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus.

Authors:  E J Wawrzynczak; R V Henry; A J Cumber; G D Parnell; E J Derbyshire; N Ulbrich
Journal:  Eur J Biochem       Date:  1991-02-26

2.  Complete nucleotide sequence of cDNA for the cytotoxin alpha sarcin.

Authors:  T Oka; Y Natori; S Tanaka; K Tsurugi; Y Endo
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  Overproduction of fungal ribotoxin alpha-sarcin in Escherichia coli: generation of an active immunotoxin.

Authors:  D Rathore; S K Nayak; J K Batra
Journal:  Gene       Date:  1997-04-29       Impact factor: 3.688

4.  Overproduction and purification of biologically active native fungal alpha-sarcin in Escherichia coli.

Authors:  J Lacadena; A Martínez del Pozo; J L Barbero; J M Mancheño; M Gasset; M Oñaderra; C López-Otín; S Ortega; J García; J G Gavilanes
Journal:  Gene       Date:  1994-05-03       Impact factor: 3.688

5.  The primary structure of the cytotoxin restrictocin.

Authors:  C López-Otín; D Barber; J L Fernández-Luna; F Soriano; E Méndez
Journal:  Eur J Biochem       Date:  1984-09-17

6.  An efficient expression system for a variant form of the cytotoxic protein alpha-sarcin in Escherichia coli.

Authors:  T Oka; Y Aoyama; Y Natori; T Katano; Y Endo
Journal:  Biochim Biophys Acta       Date:  1992-03-24

7.  The site of action of alpha-sarcin on eukaryotic ribosomes. The sequence at the alpha-sarcin cleavage site in 28 S ribosomal ribonucleic acid.

Authors:  Y Endo; I G Wool
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

8.  ALPHA SARCIN, A NEW ANTITUMOR AGENT. I. ISOLATION, PURIFICATION, CHEMICAL COMPOSITION, AND THE IDENTITY OF A NEW AMINO ACID.

Authors:  B H OLSON; G L GOERNER
Journal:  Appl Microbiol       Date:  1965-05

Review 9.  Immunotoxins: magic bullets or misguided missiles?

Authors:  E S Vitetta; P E Thorpe; J W Uhr
Journal:  Trends Pharmacol Sci       Date:  1993-05       Impact factor: 14.819

10.  Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins.

Authors:  L K Arruda; T A Platts-Mills; J W Fox; M D Chapman
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.